Sexually transmitted diseases. Evaluation of the objectives of the Health Plan for Catalonia for the year 2000;Enfermedades de transmisión sexual. Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000

Medicina Clinica

Volumn 121, Issue SUPPL.1, 2003, Pages 87-93

  Calmet, Montserrat ^a   Domínguez, Àngela ^a   Barrabeig, Irene ^a   Sanz, Benicio ^b   Armengol, Pere ^b   Boronat, Josep ^c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c Unidad de Infecciones de Transmisión Sexual   (Spain)

Author keywords

Evaluation; Health planning; Incidence; Sexually transmitted diseases

Indexed keywords

BETA LACTAMASE;

BACTERIAL STRAIN; CONGENITAL SYPHILIS; GONORRHEA; HUMAN; INCIDENCE; NEISSERIA GONORRHOEAE; NEWBORN OPHTHALMIA; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

EID: 4344580590     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Cates W, Holmes KK. Sexually transmitted diseases. In: Wallace RB, editor. Public health and preventive medicine. 14th ed. Stanford: Appleton & Lange, 1998; p. 137-67.
2. Chernesky MA. Laboratory services for sexually transmitted diseases: overview and developments. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Companies, 1999; p. 1089-132.
3. Aral SO, Holmes KK. Social and behavioral determinants of the epidemiology of STDs: industrialized and developing countries. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Companies, 1999; p. 39-76.
4. WHO. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. Geneva: World Health Organization, 2001.
5. UNAIDS. Report on the global HIV/AIDS epidemic. Joint United Nations Programme on HIV/AIDS. Geneva: UNAIDS, 2002.
6. Cates W, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771-81.
7. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease and infertility: an epidemiologic update. Epidemiol Rev 1990;12:199-219.
8. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993;69:9-17.
9. Heather Watts D, Brunham RC. Sexually transmitted diseases, including HIV infection in pregnancy. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Companies, 1999; p. 1089-132.
10. Jay N, Mosciccki B. Human papilloma virus infection in women. In: Goldman MB, Hatch MC, editors. Women and health. San Diego: Academic Press, 2000; p. 324-35.
11. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from cohort study. AIDS 1993;7:95-102.
12. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, et al. Female to male transmission of human immunodeficiency virus type I: risk factors for seroconversion in men. Lancet 1989;2:403-7.
13. Hunter DJ, Maggwa BN, Mati JK, Tukei PM, Mbugua S. Sexual behavior, sexually transmitted diseases, male circumcision, and risk of HIV infection among women in Nairobi, Kenya. AIDS 1994;8:93-9.
14. Gilson L, Mkanje R, Grosskurth H, Mosha F, Picard J, Gavyole A, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997;350:1805-9.
15. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-6.
16. Departament de Sanitat i Seguretat Social. Document marc per a l'elaboració del Pla de Salut de Catalunya. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1991.
17. Departament de Sanitat i Seguretat Social. Pla de Salut de Catalunya 1993-1995. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1993.
18. Departament de Sanitat i Seguretat Social. Pla de Salut de Catalunya 1996-1998. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1997.
19. Departament de Sanitat i Seguretat Social. Pla de Salut de Catalunya 1999-2001. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1999.
20. a ed. Barcelona: Departament de Sanitat i Seguretat Social, 1995 a 2001.
21. Centro Nacional de Epidemiología. Área de Vigilancia Epidemiológica. Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de Información Microbiológica. España. Año 2000. Boletín Epidemiológico Semanal 2001;9:10/101-12.
22. Centro Nacional de Epidemiología. Área de Vigilancia Epidemiológica. Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de Información Microbiológica. España. Año 1995. Boletín Epidemiológico Semanal 1996;4:1.
23. Centro Nacional de Epidemiología. Área de Vigilancia Epidemiológica. Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de Información Microbiológica. España. Año 1996. Boletín Epidemiológico Semanal 1997;5:1.
24. Centro Nacional de Epidemiología. Área de Vigilancia Epidemiológica. Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de Información Microbiológica. España. Año 1998. Boletín Epidemiológico Semanal 1999;7:1/1-12.
25. Junta de Castilla y León. Dirección General de Salud Pública. Servicio de Epidemiologia. Comentario epidemiológico de las enfermedades de declaración obligatoria. Año 2000. Boletín Epidemiológico de Castilla y León 2001;17:1/1-4.
26. The Gonococal Resistence to Antimicrobials Surveillance Programme (GRASP). Annual report, Year 2000 Collection. Londres: PHLS Communicable Disease Surveillance Centre, 2001.
27. O'Farrell N. Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect 1999;75:377-84.
28. Ghys PD, Diallo MO, Ettiegne-Traore V, Satten GA, Anoma CK, Maurice C, et al. Effect of interventions to control sexually transmitted disease on incidence of HIV infection in female sex workers. AIDS 2001;27;15: 1421-31.
29. Wasserheit JN. Epidemiological synergy. Interrelations between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-73.
30. Catania JA, Bindson D, Dolcini M, Strall R, Choi KH, Pallack LM, et al. Risk factors of VIH and other sexually transmitted diseases and prevention practices among US heterosexual adults: changes from 1990 to 1992. Am J P 1995;85:1492-9.
31. St Louis ME, Holmes KK. Conceptual framework for STD/HIV prevention and control. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Co., 1999; p. 1239-53.
32. Kelly JA, Sikkema KJ, Holtgrave DR. Connunity outreach and education. In: Holmes KK, Sparling PF, Mardh PA, et al, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill Co., 1999; p. 1323-8.
33. D'Souza CM, Shier LA. Prevention and intervention of sexually transmitted diseases in adolescents. Curr Opin Pediatr 1999;11:287-91.
34. a ed. Barcelona: Departament de Sanitat i Seguritat Social. Generalitat de Catalunya, 1990.
35. a ed. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1999.
36. Institut Català de la Salut. Ordenació de les activitats de prevenció i atenció a les malalties de transmissió sexual. Ámbits territorials: Bages, Granollers i Mollet. Divisió d'Atenció Primària. Institut Catalá de la Salut. Generalitat de Catalunya, 1999.
37. Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. Ordenació de les activitats de prevenció i atenció a les malalties de transmissió sexual (MTS) a la Regió Sanitària Centre. Butlletí Epidemiològic de Catalunya 1999;22:1-3.
38. Departament de Sanitat i Seguretat Social. Protocol de seguiment de l'embaràs a Catalunya. Barcelona: Departament de Sanitat i Seguretat Social. Generalitat de Catalunya, 1998.
39. Domínguez A, Capdevila JM, Sanz B, Barrabeig I, Rodés A, Casabona J, et al. Consejos para la prevención de las enfermedades de la transmisión sexual y del sida. Med Clin (Barc) 1994;102(Supl 1):118-26.
40. Departament de Sanitat i Seguretat Social. Generalitat de Catalunya. Consells per a la prevenció de les malalties de transmissió sexual i de la SIDA. En: Bases per a la integració de la prevenció a la pràctica assistencial. Barcelona, 1993.
41. Servei Català de la Salut. Criteris comuns mínims per a l'atenció a problemes de salut (II). Barcelona: Servei Català de la Salut. Generalitat de Catalunya, 1996.
42. Barrabeig I, Domínguez A. Epidemiología de las enfermedades de transmisión sexual. Jano 2000;54:806-13.
43. Calmet M, Barrabeig I, Sanz B, Armengol P, Boronat J, Villena MJ, et al. Resurgence of syhliis. Early syphilis among attenders at sexually transmitted infections units. Póster LbPeC9030. XIV International AIDS Conference 2002, Barcelona, julio 7-12.
44. PHLS, DHSS & PS and Scottish ISD(D)5 Collaborative Group. Sexually transmitted infections in the UK: new episodes seen at genitourinary medicine clinics, 1995 to 2000. London: Public Health Laboratory Service, 2001.
45. Stolte IG, Dukers NH, De Wit JB, Fennema JS, Coutinho RA. Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Trans Infect 2001;77:184-6.
46. Karlsson A, Hejdeman B, Pernetum T, Sandstrom E. HIV, gonorrhea, Chlamydia and syplilis are increasing among homosexual men. Lakartidningen 2001;98:1793-5.
47. CDSC. Syphilis in Bristol 1997-8: an update. Commun Dis Rep Wkly 1998;8:413.
48. CDSC. Increased transmission of syphilis in Brighton and Greater Manchester among men who have sex with men. Commun Dis Rep Wkly 2000;10:383-6.
49. CDSC. Increased transmission among homosexual and bisexual men in London and Manchester. Commun Dis Rep Wkly 2001;11:news. Disponible en: www.phls.co.uk/publications/CDRElectronic/CDR%weekly/CDR%20Weekly/archive. news2701.html#syphilis
50. Fenton K, Nicoll A, Kinghorn G. Resurgence of syphilis in England: time for more radical and nationallly co-ordinated approaches. Sex Transm Infect 2001;77:309-10.
51. Goeree R, Jang D, Blackhouse G, Chong S, Mahony J, Sellors J, et al. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario. Sex Transm Dis 2001;28:701-9.
52. Marinas JJ, Rego ME, Rosales M, Castro MI, Bouzas E. Evaluación de la efectividad de un programa de detección de infección asintomática por Chlamydia trachomatis en mujeres. Rev Esp Salud Pública 1997;71:27-34.
53. Goh CL, Chan RK. Prevalence of sexually transmitted diseases among commercial sex workers in Singapore from 1977 to 1993: the effects of screening measures. Ann Acad Med Singapore 1995;24:500-4.
54. Ghys PD, Diallo MO, Ettiegne-Traore V, Satten GA, Anoma CK, Maurice C, et al. Effect of interventions to control sexually transmitted disease on the incidence of infection in female sex workers. AIDS 2001;15:1421-31.
55. Shepherd J, Peersman G, Weston R, Napuli I. Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women. Health Educ Res 2000;15:681-94.
56. Artz L, Macaluso M, Brill I, Kelaghan J, Austin H, Fleenor M, et al. Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health 2000;90:237-44.
57. Scott JL, Giedt A, Dimitrievich E. A community medicine project involving an educational session in sexually transmitted diseases for high school students. S D J Med 1998;51:345-6.
58. Catchpole MA. The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med 1996;72:321-9.